Official Announcement丨Huibang Biotech has received tens of millions of RMB in B+ round of equity financing, ushering in a new era of development!

Date：

2021-12-23

Recently, Huibang Biotechnology received tens of millions of yuan in B+ round equity financing from Chuanggu Capital, an investment group in Anhui Province. The financing in this round will be used to improve the industrial chain layout and upgrade R&D capabilities.

 

Since its establishment, Huibang Biotech has been committed to precision medicine, adhered to the development path of independent innovation, and won the favor and support of various capitals by virtue of its long-term technology accumulation and forward-looking layout. After Jiaxing Qihui and Saizhi Capital completed the B round of financing, after a year of rapid development, at the end of the year, Huibang Biotech joined hands with Anhui Provincial Investment to obtain tens of millions of yuan in the B+ round of financing from Chuanggu Capital. So far, the B round of financing has completed 60 million yuan!

 

With the launch of the company's quantum dot, flow fluorescence, chemiluminescence microfluidics and other series of projects, the development of Huibang Biotechnology will enter a new era!

 

Aiming at the 100 billion market for diabetes management

Output specialized solutions

 

Venture Valley Capital


 

On January 5, 2018, Venture Valley Capital was established in Hefei High-tech Zone. This is the Anhui Provincial Investment Group’s pilot program to deepen the reform of state-owned capital investment and operation companies in order to implement the “full innovation and reform” plan and the construction of the provincial-level equity investment fund system. The company's Anhui High-tech Industry Investment Co., Ltd. is a market-oriented and professional fund management company initiated and established by the management team.

 

At present, it has undertaken the management of the provincial "three majors and one innovation" fund, the provincial small and medium-sized enterprise (specialized and special new) fund, and some sub-funds of the provincial emerging industry venture capital fund, and has raised and established several fully market-oriented funds.

 

Venture Valley Capital focuses on key industries such as TMT, general health, cultural tourism, new energy, modern agriculture, equipment manufacturing, and new materials, and builds a full life cycle fund cluster system from angels, VC, PE to mergers and acquisitions.

 

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.